Ultragyors hatású humán inzulinanalógok: Új lehetoség a cukorbetegség kezelésében

Research output: Review article


Modifications of the insulin molecule at the end of the B chain resulted in the development of some new, more physiological meal-related insulins, the rapid acting human insulin analogues. This survey summarises the characteristics (structure, absorption, immunogenicity, efficacy and safety) and the conditions of clinical application of the rapid-acting insulin analogues available at the moment in Hungary. Furthermore, authors evaluate the effect of application of rapid-acting insulin analogues on the quality of life and glycaemic control of the patients. The collaboration between the well-prepared health-care team and the well-educated and cooperative diabetic patient using rapid-acting insulin analogue could lead to a level of freedom of lifestyle that approximates that of healthy people.

Original languageHungarian
Pages (from-to)223-228
Number of pages6
JournalLege Artis Medicinae
Issue number4
Publication statusPublished - júl. 22 2002



  • Clinical application
  • Glycaemic control
  • Insulin treatment
  • Rapid acting insulin analogues

ASJC Scopus subject areas

  • Medicine(all)

Cite this